tm
Seeing Is Believing
tm
Seeing Is Believing
DYN is currently covered by 5 analysts with an average price target of $48.07. This is a potential upside of $19.45 (67.96%) from yesterday's end of day stock price of $28.62.
Dyne Therapeutics 's activity chart (see below) currently has 10 price targets and 24 ratings on display. The stock rating distribution of DYN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 68.06% with an average time for these price targets to be met of 358.5 days.
Highest price target for DYN is $66, Lowest price target is $42, average price target is $48.07.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 23-Sep-2024. First documented stock forecast 12-Oct-2020.
5/25/10 1 for 5
8/22/00 2 for 1
2/1/00 69 for 100
Currently out of the existing stock ratings of DYN, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$53
$24.26 (84.41%)
$53
1 months 13 days ago
(23-Sep-2024)
4/6 (66.67%)
$18.37 (53.05%)
761
Buy
$66
$37.26 (129.65%)
2 months 20 days ago
(16-Aug-2024)
2/3 (66.67%)
$20.61 (45.41%)
593
Buy
$42
$13.26 (46.14%)
$31
5 months 15 days ago
(21-May-2024)
5/5 (100%)
$9.37 (28.72%)
222
Buy
$56
$27.26 (94.85%)
$27
10 months 1 days ago
(04-Jan-2024)
3/4 (75%)
$36.61 (188.81%)
286
Buy
$22
$-6.74 (-23.45%)
$18
1 years 2 months 27 days ago
(09-Aug-2023)
2/2 (100%)
$11.42 (107.94%)
289
What is DYN (Dyne Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on DYN (Dyne Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?
Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?
Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?
